Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM2 | P50570 | 11/20 | 0.36 |
| ▸ | MMP3 | P08254 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.30 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21231253 | 0.98 | DNM2 (0.39) | DNM2MMP3ALDH1A1TSHREPHX1 | |
| SCHEMBL22645847 | 0.86 | — | — | |
| SCHEMBL21231196 | 0.86 | MMP3 (0.34) | DNM2MMP3ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL22943378 | 0.85 | EPHX1 (0.31) | EPHX1 | |
| SCHEMBL24807494 | 0.84 | MMP3 (0.36) | DNM2MMP3EPHX1 | |
| SCHEMBL22645854 | 0.84 | GPR84 (0.34) | DNM2MMP3ALDH1A1GPR84 | |
| SCHEMBL22645831 | 0.84 | GPR84 (0.34) | DNM2MMP3ALDH1A1GPR84 | |
| SCHEMBL21231187 | 0.84 | MMP3 (0.35) | DNM2MMP3ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL24806623 | 0.83 | DNM2 (0.36) | DNM2MMP3GPR84 | |
| SCHEMBL24937234 | 0.81 | TSHR (0.30) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020227510-A1 | POLYNUCLEOTIDES FOR DISRUPTING IMMUNE CELL ACTIVITY AND METHODS OF USE THEREOF | MODERNATX, INC. (US) | 2020-11-12 | — | — | WO | disclosed |